{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-196966","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.557536+00:00","generated_at":"2026-05-31T11:08:02.899774+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aligos appoints Heather Preston and Margarita Chavez to Board","bullets":["Board expanded to seven directors; Preston and Chavez appointed as Class II directors through 2025 annual meeting.","Dr. Preston will chair the Nominating Committee; Ms. Chavez joins the Audit Committee.","Each receives $40k annual retainer (prorated) and an initial option for 120,000 shares.","Chavez gets additional $7,500/yr for Audit; Preston gets $8,000/yr for Nominating chair (both prorated).","Both entered standard indemnification agreements; no material relationships requiring disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-196966","json":"https://secwatch.observer/filing/0001193125-24-196966.json","markdown":"https://secwatch.observer/filing/0001193125-24-196966.md","text":"https://secwatch.observer/filing/0001193125-24-196966.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312524196966/0001193125-24-196966-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312524196966/d875950d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:08:02.899774+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0b5e55506b","claim":"Heather Preston was appointed as Director at Aligos Therapeutics, Inc..","evidence_excerpt":"appointed Heather Preston, M.D. and Margarita Chavez, J.D., to the Board to fill the newly created directorships","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799448/000119312524196966/0001193125-24-196966-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"955d519ce9","claim":"Margarita Chavez was appointed as Director at Aligos Therapeutics, Inc..","evidence_excerpt":"appointed Heather Preston, M.D. and Margarita Chavez, J.D., to the Board to fill the newly created directorships","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799448/000119312524196966/0001193125-24-196966-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}